CLDX FY 2009 Earnings — Celldex Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CLDXCelldex Therapeutics, Inc.

$2B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+103.6% YoY

Gross Profit

$7M44.7% margin

Operating Income

-$33M-216.4% margin

Net Income

-$37M-240.6% margin

EPS (Diluted)

$-27.64

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$140M

Total Liabilities

$67M

Stockholders' Equity

$74M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$7M	+103.6%
Gross Profit	$7M	$7M	-9.0%
Operating Income	-$33M	-$34M	+3.4%
Net Income	-$37M	-$48M	+23.1%